Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial.

By R. Gray, G. Kigozi, D. Serwadda, F. Makumbi, S. Watya, F. Nalugoda, N. Kiwanuka, L. Moulton, Mohammad A Chaudhary, Michael Z. Chen and 9 more. The Lancet, 2007

2,161 citations recorded by the source corpus.

Subfields: Public Health, Environmental and Occupational Health, Surgery, Urology

View Paper: https://www.semanticscholar.org/paper/1d5b87ad473c97e662f0a66c1842e25c2cbeeca3

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. Q. Abdool Karim
2. A. Kharsany
3. S. A. Abdool Karim
4. J. Frohlich
5. A. Grobler
6. C. Baxter
7. L. Mansoor
8. S. Sibeko

Citations in the corpus

• Effectiveness and Safety of Tenofovir Gel, an Antiretroviral Microbicide, for the Prevention of HIV Infection in Women (2010, positive): “The successful trials tested medical male circumcision in South Africa (4), Kenya (5), and Uganda (6) (combined effectiveness in reducing HIV acquisition was 57%), sexually transmitted infection (STI) treatment in Tanzania (effectiveness in reducing HIVacquisition was 42”
• Advances in male contraception. (2008, background): “In particular, although male circumcision has recently been shown to significantly reduce male transmission of HIV (18), the condom remains the most effective way of preventing HIV transmission during sexual contact.”
• Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial. (2007, positive): “However, there is actually no evidence of men increasing their risk behaviors after circumcision in the context of either the clinical trials or the subsequent scale-up of MC for HIV prevention (Auvert et al. 2007; Gray et al. 2007)).”